Inicio/Compuestos/Intermediario farmacéutico/Carbamic acid, N-((3aS,4R,6S,6aR)-tetrahydro-6-hydroxy-2,2-dimethyl-4H-cyclopenta-1,3-dioxol-4-yl)-, phenylmethyl ester
C32H42N2O10
614.7 g/mol
Intermediario farmacéuticoAtención
Carbamic acid, N-((3aS,4R,6S,6aR)-tetrahydro-6-hydroxy-2,2-dimethyl-4H-cyclopenta-1,3-dioxol-4-yl)-, phenylmethyl ester
CAS274693-53-7EC700-846-7
Categoría
Intermediario farmacéutico
Clase de Compuesto
Heterociclo
Uso Principal
Intermediario farmacéutico
This compound is a pharmaceutical intermediate featuring both acetal and carbamate functional groups, specifically a benzyl carbamate derivative of a cyclopenta-dioxolol. Its structure is characterized by multiple stereocenters and a bicyclic system with hydroxyl and ether moieties, making it a building block for complex molecule synthesis.
Pharmaceutical intermediate for research and manufacturingBuilding block for organic synthesis
Alcance del contenido: La información de esta página se refiere a la identificación química y a los contextos de suministro industrial, investigación y producción. No constituye una afirmación terapéutica, un consejo médico ni instrucciones de uso de medicamentos.
¿Adquiriendo o suministrando este compuesto?
Publique su inventario o una solicitud de compra
CAS 274693-53-7
Compuestos relacionados
ReferenciaMisma categoría
2-[[(3aR,4S,6R,6aS)-6-Aminotetrahydro-2,2-dimethyl-4H-cyclopenta-1,3-dioxol-4-yl]oxy]ethanol
CAS274693-55-9
Pharmaceutical intermediate
ReferenciaMisma categoría
(3,4-Diethoxyphenyl)acetonitrile
CAS27472-21-5
Pharmaceutical intermediate
ReferenciaMisma categoría
3-[[(2R,3R,4R,5R)-2-[(1S)-1-[bis(4-methoxyphenyl)-phenyl-methoxy]ethyl]-5-(2,4-dioxopyrimidin-1-yl)-4-methoxy-tetrahydrofuran-3-yl]oxy-(diisopropylamino)phosphanyl]oxypropanenitrile
CAS2747890-15-7
nucleoside phosphoramidite for oligonucleotide synthesis
ReferenciaMisma categoría
TERT-BUTYL (2S)-2-AMINO-4-METHYLPENTANOATE HYDROCHLORIDE
CAS2748-02-9
Leucine derivative pharmaceutical intermediate
Referenciastereoisomer of
Benzyl((3aR,4S,6R,6aS)-6-hydroxy-2,2-dimethyltetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-yl)carbamate
CAS88756-84-7
Pharmaceutical intermediate or impurity reference standard
Referenciasame scaffold
Phenylmethyl N-[(3aS,4R,6S,6aR)-tetrahydro-6-(2-hydroxyethoxy)-2,2-dimethyl-4H-cyclopenta-1,3-dioxol-4-yl]carbamate
CAS274693-54-8
Pharmaceutical intermediate synthesis
Referenciasame scaffold
Ethyl 2-(((3aR,4S,6R,6aS)-6-(((benzyloxy)carbonyl)amino)-2,2-dimethyltetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-yl)oxy)acetate
CAS866551-95-3
pharmaceutical intermediate
Referencia de Seguridad
Atención
H361Suspected of damaging fertility or the unborn child
Identificadores
Nombre IUPAC
benzyl N-[(3aR,4S,6R,6aS)-4-hydroxy-2,2-dimethyl-4,5,6,6a-tetrahydro-3aH-cyclopenta[d][1,3]dioxol-6-yl]carbamate
InChIKey
NZWQSYTXYZYUNP-QONRVRNRSA-N
SMILES
CC1(O[C@H]2[C@@H](C[C@@H]([C@H]2O1)O)NC(=O)OCC3=CC=CC=C3)C.CC1(O[C@H]2[C@@H](C[C@@H]([C@H]2O1)O)NC(=O)OCC3=CC=CC=C3)C
Sinónimos (1)
—